Intracel OncoVAX Phase III Will Follow Patients For Three Years
This article was originally published in The Pink Sheet Daily
Firm says single pivotal trial of the autologous cancer vaccine can support a BLA for adjuvant treatment of Stage II colon cancer.
You may also be interested in...
Non-registration Phase III trial shows extension in survival for Oncophage-treated arm in category M1a stage IV melanoma.
Decision to move ahead follows talks with FDA suggesting existing data are sufficient for filing, despite failure of one of two pivotal trials.
Round-up of late summer applications recently submitted to US FDA, adapted from the Pink Sheet FDA Performance Tracker's User Fee Goal Dates chart.